These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38577702)

  • 1. High prevalence of ceftriaxone-resistant and XDR
    Ouk V; Heng LS; Virak M; Deng S; Lahra MM; Frankson R; Kreisel K; McDonald R; Escher M; Unemo M; Wi T; Maatouk I;
    JAC Antimicrob Resist; 2024 Apr; 6(2):dlae053. PubMed ID: 38577702
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Kittiyaowamarn R; Girdthep N; Cherdtrakulkiat T; Sangprasert P; Tongtoyai J; Weston E; Borisov A; Dunne EF; Chinhiran K; Woodring J; Ngarmjiratam N; Masciotra S; Frankson R; Sirivongrangson P; Unemo M; Wi T
    JAC Antimicrob Resist; 2023 Dec; 5(6):dlad139. PubMed ID: 38115859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013-2018.
    Boiko I; Golparian D; Krynytska I; Bezkorovaina H; Frankenberg A; Onuchyna M; Jacobsson S; Unemo M
    APMIS; 2019 Jul; 127(7):503-509. PubMed ID: 30903707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009-2019.
    Aniskevich A; Shimanskaya I; Boiko I; Golubovskaya T; Golparian D; Stanislavova I; Jacobsson S; Adaskevich A; Unemo M
    BMC Infect Dis; 2021 Jun; 21(1):520. PubMed ID: 34078300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility in
    Latif AS; Gwanzura L; Machiha A; Ndowa F; Tarupiwa A; Gudza-Mugabe M; Shukusho FD; Chakanyuka Musanhu C; Wi T; Unemo M
    Sex Transm Infect; 2018 Feb; 94(1):62-66. PubMed ID: 28476914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
    Day MJ; Jacobsson S; Spiteri G; Kulishev C; Sajedi N; Woodford N; Blumel B; van der Werf MJ; Amato-Gauci AJ; Unemo M; Cole MJ;
    BMC Infect Dis; 2022 Jun; 22(1):524. PubMed ID: 35672671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance and molecular epidemiological typing of Neisseria gonorrhoeae isolates from Kyrgyzstan in Central Asia, 2012 and 2017.
    Karymbaeva S; Boiko I; Jacobsson S; Mamaeva G; Ibraeva A; Usupova D; Golparian D; Unemo M
    BMC Infect Dis; 2021 Jun; 21(1):559. PubMed ID: 34118893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility in
    Birhanu M; Abegaz WE; Schröder D; Mihret A; Abebe T; Jacobsson S; Tasew G; Addis T; Abdeta A; Alem Y; Desalegn Z; Ademe M; Teka B; Yohannes M; Yigeremus M; Golparian D; Gebre-Selassie S; Unemo M
    JAC Antimicrob Resist; 2024 Feb; 6(1):dlae002. PubMed ID: 38304725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
    Day MJ; Spiteri G; Jacobsson S; Woodford N; Amato-Gauci AJ; Cole MJ; Unemo M;
    BMC Infect Dis; 2018 Dec; 18(1):609. PubMed ID: 30509194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016.
    Jacobsson S; Cole MJ; Spiteri G; Day M; Unemo M;
    BMC Infect Dis; 2021 Mar; 21(1):273. PubMed ID: 33736608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.
    Cole MJ; Spiteri G; Jacobsson S; Woodford N; Tripodo F; Amato-Gauci AJ; Unemo M;
    BMC Infect Dis; 2017 Sep; 17(1):617. PubMed ID: 28893203
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Li X; Le W; Lou X; Wang B; Genco CA; Rice PA; Su X
    Microbiol Spectr; 2021 Oct; 9(2):e0018121. PubMed ID: 34668731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First nationwide antimicrobial susceptibility surveillance for Neisseria gonorrhoeae in Brazil, 2015-16.
    Bazzo ML; Golfetto L; Gaspar PC; Pires AF; Ramos MC; Franchini M; Ferreira WA; Unemo M; Benzaken AS;
    J Antimicrob Chemother; 2018 Jul; 73(7):1854-1861. PubMed ID: 29635367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study.
    Unemo M; Lahra MM; Escher M; Eremin S; Cole MJ; Galarza P; Ndowa F; Martin I; Dillon JR; Galas M; Ramon-Pardo P; Weinstock H; Wi T
    Lancet Microbe; 2021 Nov; 2(11):e627-e636. PubMed ID: 35544082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of
    Blouin K; Lefebvre B; Trudelle A; Defay F; Perrault Sullivan G; Ezin Aloffan LND; Labbé AC
    BMJ Open; 2023 Aug; 13(8):e073849. PubMed ID: 37541749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a standardised and quality-assured enhanced gonococcal antimicrobial surveillance programme in accordance with WHO protocols in Kampala, Uganda.
    Kakooza F; Musinguzi P; Workneh M; Walwema R; Kyambadde P; Mande E; Lubega C; Nakasi JM; Kiggundu R; Hamill MM; Bagaya BS; Lamorde M; Unemo M; Manabe YC
    Sex Transm Infect; 2021 Jun; 97(4):312-316. PubMed ID: 33082237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial Resistance of Neisseria Gonorrhoeae in a Newly Implemented Surveillance Program in Uganda: Surveillance Report.
    Workneh M; Hamill MM; Kakooza F; Mande E; Wagner J; Mbabazi O; Mugasha R; Kajumbula H; Walwema R; Zenilman J; Musinguzi P; Kyambadde P; Lamorde M; Manabe YC
    JMIR Public Health Surveill; 2020 Jun; 6(2):e17009. PubMed ID: 32519969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.
    Jabeen K; Bhawan Mal P; Khan E; Chandio S; Jacobsson S; Unemo M
    BMC Infect Dis; 2016 Jul; 16():353. PubMed ID: 27449234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance.
    Cole MJ; Spiteri G; Jacobsson S; Pitt R; Grigorjev V; Unemo M;
    BMC Infect Dis; 2015 Aug; 15():321. PubMed ID: 26259560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.